Discovery Of First Gene For Most Common Form Of Epilepsy

Main Category: Epilepsy
Also Included In: Genetics;  Pediatrics / Children's Health
Article Date: 29 Jan 2009 - 2:00 PST

email to a friend   printer friendly   view / write opinions

An international team of researchers, led by investigators at Columbia University Medical Center, has uncovered the first gene linked to the most common type of epilepsy, called Rolandic epilepsy. One out of every five children with epilepsy is diagnosed with this form, which is associated with seizures starting in one part of the brain.

Results of the study were published in an advance online issue of the European Journal of Human Genetics on January 28, 2009.

The finding is the first step in unlocking the causes of common childhood epilepsies and developing more effective treatments. Children with Rolandic and other types of epilepsies are usually treated with drugs that prevent seizures by suppressing electrical activity in the entire brain.

"Epilepsy medications are effective for many children but there is concern that some of the cognitive and behavioral problems that children with epilepsy often suffer might be attributable in part to these drugs," says the study's senior author, pediatric neurologist Deb Pal, M.D., Ph.D., Columbia University research scientist in the Department of Psychiatry at the College of Physicians & Surgeons and at the Mailman School of Public Health and in the Division of Epidemiology at the New York State Psychiatric Institute. "Most epilepsies have a genetic influence, much of which has yet to be discovered. If we knew the actual genetic causes, then we could try to stop or reverse the processes that lead to seizures and other neurological impairments. This finding will hopefully help lead us to the right intervention."

In the study, the researchers searched the entire genome of 38 families and found a region on chromosome 11 that was linked with Rolandic epilepsy. Then, by comparing this region in people with Rolandic epilepsy to unaffected controls (255 people in total), the researchers pinpointed the gene, called ELP4.

The finding was replicated in a completely different set of patients and controls collected by the team's Canadian members, with the same result. Though Dr. Pal says an outside group still needs to replicate the findings, the two independent experiments provide strong evidence that ELP4 is truly linked to Rolandic epilepsy.

ELP4 has never before been linked to a human disease but is related to a group of genes (transcriptional regulators) that recently have been associated with other common forms of epilepsy. All these genes appear to influence the organization of brain circuits during development.

The discovery of genes like ELP4 are slowly altering the prevailing view of the cause of common epilepsies. Instead of stemming from changes in the brain's ion channels, as previously thought, the disorders likely stem from the way the brain's neurons connect to each other during development, researchers now believe.

With that perspective, it is not surprising that children with epilepsy often have other learning and behavior problems. "We shouldn't think of epilepsy as just about the seizures, but also about all the other brain impairments we see, like a delay in speaking, reading difficulties, and attention problems," Dr. Pal says. "Seizures are one, but not the only, consequence of these children's slightly altered brain development."

The findings also offer possible insights into the causes of attention deficit hyperactivity disorder (ADHD), speech dyspraxia (a speech disorder in which a person has a delay in speech development due to motor coordination difficulties), and developmental coordination disorder (DCD). Children with these developmental disorders often have the same spiky brainwave pattern that is present in children with Rolandic epilepsy. Understanding how the ELP4 gene is related to the brainwave pattern may help researchers uncover the causes of these disorders.

Rolandic epilepsy, named for the region of the brain affected by the seizures, begins almost exclusively in children between the ages of 3 and 12. Seizures typically start in the morning just after the child wakes up and cause a loss of muscle tone in the face and a loss of speech. Seizures stop on their own after several minutes. Most children grow out of the disorder by adolescence.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

Additional authors of this study include Lisa Strug, Ph.D., formerly an assistant professor with Columbia University Mailman School of Public Health's Department of Biostatistics, Division of Statistical Genetics.

The study was supported by members of the Partnership for Pediatric Epilepsy Research (American Epilepsy Society, Epilepsy Foundation, Anna and Jim Fantaci, Fight Against Childhood Epilepsy and Seizures, Neurotherapy Ventures Charitable Research Fund, Parents Against Childhood Epilepsy); Epilepsy Foundation, through the generous support of the Charles L. Shor Foundation for Epilepsy Research, Inc.; and the NIH.

Columbia University Medical Center provides international leadership in basic, pre-clinical and clinical research, in medical and health sciences education, and in patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Established in 1767, Columbia's College of Physicians and Surgeons was the first institution in the country to grant the M.D. degree and is among the most selective medical schools in the country. Columbia University Medical Center is home to the largest medical research enterprise in New York City and state and one of the largest in the United States. For more information, please visit http://www.cumc.columbia.edu/

The Columbia Comprehensive Epilepsy Center is internationally known for providing state of the art evaluation and treatment of people with epilepsy, as well as research toward better understanding and treatment of all types of epilepsy.

Source: Karin Eskenazi
Columbia University Medical Center